Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Debt / NOTE 4/0
-
Market price (% of par)
-
94.7%
-
Total 13F principal
-
$581,292,500
-
Principal change
-
+$53,605,805
-
Total reported market value
-
$550,280,148
-
Number of holders
-
49
-
Value change
-
+$51,108,656
-
Number of buys
-
20
-
Number of sells
-
18
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2023
As of 30 Jun 2023,
IONIS PHARMACEUTICALS INC - NOTE 4/0 was held by
49 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$581,292,500
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, BRAIDWELL LP, BlackRock Inc., CSS LLC/IL, MACKAY SHIELDS LLC, Magnetar Financial LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, and Calamos Advisors LLC.
This page lists
49
institutional bondholders reporting positions
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.